Boudreaux's New Drug Store
“What pharmacy does OurView use? OurView's partners with Boudreaux's New Drug Store, a licensed 503A compounding pharmacy located in Louisiana. The pharmacy compounds and ships medications for OurView patients nationwide”
OurView Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 9.2/10
Best for: low month-to-month compounded GLP-1 pricing with no membership fee
9.2
★★★★★9.2/10
OurView Health scores highest on price and lowest on follow-up care. It charges from $109 a month; its compounded tirzepatide, at $129, is 52% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
$109/mo
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
See plans →See plans at OurView Health →
Compare top-rated alternatives ↓Prices checked October 2026
OurView Health sells compounded semaglutide at $109 a month and compounded tirzepatide at $129, one price whatever the dose, with no membership fee and free shipping. Paying 3 months up front lowers that to $99 and $119. Prescribers come from Telegra's network, and Boudreaux's New Drug Store in Louisiana compounds and ships the medication. It serves 46 states plus DC and also sells hormone care and peptides.
By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
GLP-1 from $109/moPrice shown up frontIncludes medication + consult46 states and DCPharmacy namedNo FDA warning letters found
Is OurView Health legit?
Yes. OurView Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 9.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an OurView Health promo or coupon code?
We know of no promo or coupon code for OurView Health. Its listed price is $109 a month. Coupon sites advertising "OurView Health discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how OurView Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to OurView Health
9.3/ 10
Verified partnerEmbody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
★★★★★9.3/10
Editorial score · methodology
$79/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full Embody review →9.1/ 10
Verified partnerCollective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
★★★★★9.1/10
Editorial score · methodology
$59/mo+ membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →7.4/ 10
Verified partnerAgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
★★★★☆7.4/10
Editorial score · methodology
$99/moprepaid
CompoundedSemaglutideTirzepatideGHK-CuGlutathione
Get StartedRead full AgelessRx review →OurView Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $109/mo (3 months paid in full: $297 ($99/mo).)
- What's included
- Medication · Consult · Shipping
- Availability
- 46 states + DC
- FDA status
- No FDA warning letters found
How OurView Health scores
Six columns, each one computed from something OurView Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
10.0/10$129/month is 52% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
9.0/10It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
9.4/10Serves 46 of 50 states and DC.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
6weighted dimensions
734sellers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on OurView Health
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: 46 states
- Checked what the monthly price covers, and what it leaves out
- Recorded which pharmacies the seller names as filling its prescriptions, with the page and date
- Checked FDA warning letters for OurView Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with OurView Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1OurView Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Boudreaux's New Drug Store fills the prescriptions, and OurView Health names it publicly, which most sellers do not.
- 3The monthly price includes the medication, clinician visits and shipping.
Price shown before you start
- Lowest ongoing monthly price: semaglutide $109, tirzepatide $129. That leaves out membership fees, first-month rates and insurance copays.
- OurView Health serves 46 of 50 states and DC, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting OurView Health
- Phone
- (573) 685-6155
- OurView Health offers email support
Cancelling OurView Health
Taken from the terms OurView Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Month to month, or a 3-month plan paid at checkout
- Refund policy
- No refunds on prescriptions after the charge goes through and the order ships
- Early-termination fee
- None
Medications OurView Health lists
OurView Health lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides OurView Health offers
OurView Health sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Injectable, month-to-month (any prescribed dose)Compounded
$109/mo
semaglutide
3 months paid in full: $297 ($99/mo).
Injectable, month-to-month (any prescribed dose)Compounded
$129/mo
tirzepatide
3 months paid in full: $357 ($119/mo).
Check the price yourself before you pay
Every figure here comes from OurView Health's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
OurView Health compounding-pharmacy partners
OurView Health names each pharmacy below as one that compounds or fills its prescriptions, in its own site, terms or filings. The quote under each one is the seller’s own wording.
In its favor
- Semaglutide costs $109 a month, 45% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $129 a month, 52% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves 46 states and DC
- Names Boudreaux's New Drug Store as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to OurView Health
Against it
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What OurView Health charges
The standing price at OurView Health is $109/month.
- Compounded semaglutide: $109/month
- Compounded tirzepatide: $129/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so OurView Health's $129 is genuinely below the middle, not just advertised that way. Before you pay, compare OurView Health's cancellation terms with other sellers' cancellation and refund policies. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
Oak dispenses semaglutide and tirzepatide from $100/month, which makes it the fair comparison to run before you commit here.
What OurView Health dispenses
OurView Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
OurView Health tells you its price before you start the medical questionnaire, the 46 states it serves, and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to OurView Health. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. The FDA publishes seven warning signs for telehealth medicine sellers, and they take a minute to run against OurView Health. How we weigh oversight, disclosure and price is set out in our scoring methodology.
OurView Health also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether OurView Health bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
OurView Health competes on price without an obvious sacrifice elsewhere: $129/month for compounded tirzepatide, no FDA warning letters, and wide state coverage.
The Bottom Line
OurView Health scores highest on price and lowest on follow-up care. It charges from $109 a month; its compounded tirzepatide, at $129, is 52% below the $269 median among the sellers we compare.
Score: 9.2/10Best for: low month-to-month compounded GLP-1 pricing with no membership feeFrom: $109/mo
Before you pay OurView Health
Starting at $109 a month. Check today's price, then start the intake.
Where OurView Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to OurView Health sets more sellers in the same category beside OurView Health on price, states and what the price includes.
Frequently Asked Questions
OurView Health sells compounded semaglutide at $109 a month and compounded tirzepatide at $129, one price whatever the dose, with no membership fee and free shipping. Paying 3 months up front lowers that to $99 and $119. Prescribers come from Telegra's network, and Boudreaux's New Drug Store in Louisiana compounds and ships the medication. It serves 46 states plus DC and also sells hormone care and peptides. We rate it 9.2/10 overall.
OurView Health starts at $109 a month. The pricing table above lists every tier.
OurView Health names 46 states. Check that yours is on the list before you go any further.
OurView Health lists compounded semaglutide and compounded tirzepatide.
OurView Health lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Check whether OurView Health bills your insurance before you sign up. Compounded GLP-1s are rarely covered by insurance, so plan on paying the listed cash price.
OurView Health says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what is included and what is not.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. OurView Health runs that whole sequence on its own site.
We found no FDA warning letters issued to OurView Health. Before you buy, weigh these: Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of them rules OurView Health out, but each is worth settling before you pay.
Other sellers we cover include Oak, SnagRx, and Lttl. Which one fits depends on the medication, the monthly price you can sustain and whether it ships to your state, so compare those three facts before you switch.
How to check OurView Health yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Arizona, California, Idaho, New York, Ohio, Rhode Island, West Virginia, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this OurView Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See OurView Health's current pricing
Plans start at $109 a month. Whether you qualify is a clinician's decision, made after your intake.
Not sold on OurView Health?
Vetted alternatives